Session information

Oral Presentation

(E) Pharmaceutical Health Care and Sciences

[28PS1-am] Development of novel medicines and formulations

Tue. Mar 28, 2023 11:10 AM - 12:10 PM [Room PS1] (1F)

Chair: Kousei Ito, Tomohiro Omura

+Add all to schedule

11:10 AM - 11:22 AM

[28PS1-am01S] Rebamipide nanogel formulation based on gum arabic and carboxy vinyl polymer provides early therapy of oral mucositis

○Saori Deguchi¹, Miku Nishida¹, Miri Komatsu¹, Hikaru Wakuda¹, Hiroko Otake¹, Noriaki Nagai¹ (1. Pharm., Kindai Univ.)

11:22 AM - 11:34 AM

[28PS1-am02S] The evaluation of the growth inhibitory effect of Streptococcus mutans using fluoride-containing oral patch

○Himawari Kimura¹, Yoichi Yamada², Eiichi Toorisaka³, Joma Ito¹, Akari Kawanaka¹, Humina Yano¹, Hiroshige Ono¹ (1. Sanyo-Onoda City University, 2. Shujitsu University, 3. Yamaguchi University)

11:34 AM - 11:46 AM

[28PS1-am03S] Improved oral absorption of cannabidiol by solid lipid nanoparticles

○Monami Sugihara¹, Kohei Yamada¹, Hideyuki Sato¹, Robert K. Prud’homme², Satomi Onoue¹ (1. Sch. Pharm. Sci., Univ. of Shizuoka, 2. Princeton Univ.)

11:46 AM - 11:58 AM

[28PS1-am04S] Development of dry powder inhaler of meloxicam for the treatment of airway inflammatory diseases

○Kazuki Masui¹, Atsushi Uchida^1,2, Kohei Yamada¹, Hideyuki Sato¹, Satomi Onoue¹ (1. Sch. Pharm. Sci., Univ. Shizuoka., 2. Dept. Pharm., Univ. Yamanashi Hosp.)

11:58 AM - 12:10 PM

[28PS1-am05S] Invention of the Bispecific T-cell Engager antibody based cyclic single-chain antibodies and evaluation for drug design development

○Mizuki Ogawa¹, Mana Namikawa², Shosei Kai², Yifan Yang¹, Rui Shi¹, Takashi Sato¹, Yoshihiro Kobashikawa¹, Hiroshi Morioka¹ (1. Grad.Sch.Pharm.Sci.,Kumamoto Univ., 2. Sch.Pharm.Kumamoto Univ.)

Authentication

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Please log in with your participant account.
» Participant Log In

▲